Cargando…

Pulmonary Hypertension in Parenchymal Lung Disease

Idiopathic pulmonary arterial hypertension (IPAH) has been extensively investigated, although it represents a less common form of the pulmonary hypertension (PH) family, as shown by international registries. Interestingly, in types of PH that are encountered in parenchymal lung diseases such as inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsangaris, Iraklis, Tsaknis, Georgios, Anthi, Anastasia, Orfanos, Stylianos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474989/
https://www.ncbi.nlm.nih.gov/pubmed/23094153
http://dx.doi.org/10.1155/2012/684781
_version_ 1782246873903398912
author Tsangaris, Iraklis
Tsaknis, Georgios
Anthi, Anastasia
Orfanos, Stylianos E.
author_facet Tsangaris, Iraklis
Tsaknis, Georgios
Anthi, Anastasia
Orfanos, Stylianos E.
author_sort Tsangaris, Iraklis
collection PubMed
description Idiopathic pulmonary arterial hypertension (IPAH) has been extensively investigated, although it represents a less common form of the pulmonary hypertension (PH) family, as shown by international registries. Interestingly, in types of PH that are encountered in parenchymal lung diseases such as interstitial lung diseases (ILDs), chronic obstructive pulmonary disease (COPD), and many other diffuse parenchymal lung diseases, some of which are very common, the available data is limited. In this paper, we try to browse in the latest available data regarding the occurrence, pathogenesis, and treatment of PH in chronic parenchymal lung diseases.
format Online
Article
Text
id pubmed-3474989
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34749892012-10-23 Pulmonary Hypertension in Parenchymal Lung Disease Tsangaris, Iraklis Tsaknis, Georgios Anthi, Anastasia Orfanos, Stylianos E. Pulm Med Review Article Idiopathic pulmonary arterial hypertension (IPAH) has been extensively investigated, although it represents a less common form of the pulmonary hypertension (PH) family, as shown by international registries. Interestingly, in types of PH that are encountered in parenchymal lung diseases such as interstitial lung diseases (ILDs), chronic obstructive pulmonary disease (COPD), and many other diffuse parenchymal lung diseases, some of which are very common, the available data is limited. In this paper, we try to browse in the latest available data regarding the occurrence, pathogenesis, and treatment of PH in chronic parenchymal lung diseases. Hindawi Publishing Corporation 2012 2012-10-10 /pmc/articles/PMC3474989/ /pubmed/23094153 http://dx.doi.org/10.1155/2012/684781 Text en Copyright © 2012 Iraklis Tsangaris et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tsangaris, Iraklis
Tsaknis, Georgios
Anthi, Anastasia
Orfanos, Stylianos E.
Pulmonary Hypertension in Parenchymal Lung Disease
title Pulmonary Hypertension in Parenchymal Lung Disease
title_full Pulmonary Hypertension in Parenchymal Lung Disease
title_fullStr Pulmonary Hypertension in Parenchymal Lung Disease
title_full_unstemmed Pulmonary Hypertension in Parenchymal Lung Disease
title_short Pulmonary Hypertension in Parenchymal Lung Disease
title_sort pulmonary hypertension in parenchymal lung disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474989/
https://www.ncbi.nlm.nih.gov/pubmed/23094153
http://dx.doi.org/10.1155/2012/684781
work_keys_str_mv AT tsangarisiraklis pulmonaryhypertensioninparenchymallungdisease
AT tsaknisgeorgios pulmonaryhypertensioninparenchymallungdisease
AT anthianastasia pulmonaryhypertensioninparenchymallungdisease
AT orfanosstylianose pulmonaryhypertensioninparenchymallungdisease